{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T04:09:37Z","timestamp":1769918977649,"version":"3.49.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed.)"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.endien.2024.03.020","type":"journal-article","created":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T13:17:40Z","timestamp":1720444660000},"page":"263-270","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Carcinoid crisis: The challenge is still there"],"prefix":"10.1016","volume":"71","author":[{"given":"Fernando","family":"Guerrero-P\u00e9rez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inmaculada","family":"Peir\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 L.","family":"Vercher-Conejero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Teul\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carles","family":"Villabona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.endien.2024.03.020_bib0240","doi-asserted-by":"crossref","first-page":"e13146","DOI":"10.1111\/jne.13146","article-title":"European Neuroendocrine Tumor Society (ENETS) 2022 guidance paper for carcinoid syndrome and carcinoid heart disease","volume":"34","author":"Grozinsky-Glasberg","year":"2022","journal-title":"J Neuroendocrinol"},{"key":"10.1016\/j.endien.2024.03.020_bib0245","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.3390\/ijms24043610","article-title":"Carcinoid syndrome: preclinical models and future therapeutic strategies","volume":"24","author":"Vitale","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.endien.2024.03.020_bib0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MPA.0000000000001454","article-title":"The North American Neuroendocrine Tumor Society consensus paper on the surgical management of pancreatic neuroendocrine tumors","volume":"49","author":"Howe","year":"2020","journal-title":"Pancreas"},{"key":"10.1016\/j.endien.2024.03.020_bib0255","unstructured":"National Comprehensive Cancer Network. Neuroendocrine and adrenal tumors (version 1.2023). http:\/\/www.nccn.org [accessed December 2023]."},{"key":"10.1016\/j.endien.2024.03.020_bib0260","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1001\/archinte.1964.03860070072004","article-title":"The carcinoid crisis","volume":"114","author":"Kahil","year":"1964","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.endien.2024.03.020_bib0265","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/MPA.0000000000001271","article-title":"Periprocedural management of patients undergoing liver resection or embolotherapy for neuroendocrine tumor metastases","volume":"48","author":"Kwon","year":"2019","journal-title":"Pancreas"},{"key":"10.1016\/j.endien.2024.03.020_bib0270","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/jso.23323","article-title":"Octreotide LAR and bolus octreotide are insufficient for preventing intraoperative complications in carcinoid patients","volume":"107","author":"Massimino","year":"2013","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.endien.2024.03.020_bib0275","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jclinane.2016.03.008","article-title":"Development of effective prophylaxis against intraoperative carcinoid crisis","volume":"32","author":"Woltering","year":"2016","journal-title":"J Clin Anesth"},{"key":"10.1016\/j.endien.2024.03.020_bib0280","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jclinane.2018.08.005","article-title":"Partial hepatic resections for metastatic neuroendocrine tumors: perioperative outcomes","volume":"51","author":"Kinney","year":"2018","journal-title":"J Clin Anesth"},{"key":"10.1016\/j.endien.2024.03.020_bib0285","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.surg.2018.04.093","article-title":"A prospective study of the pathophysiology of carcinoid crisis","volume":"165","author":"Condron","year":"2019","journal-title":"Surgery"},{"key":"10.1016\/j.endien.2024.03.020_bib0290","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1530\/EC-18-0324","article-title":"Intraoperative carcinoid syndrome during small-bowel neuroendocrine tumour surgery","volume":"7","author":"Fouch\u00e9","year":"2018","journal-title":"Endocr Connect"},{"key":"10.1016\/j.endien.2024.03.020_bib0295","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.surg.2015.05.036","article-title":"Continuous infusion of octreotide combined with perioperative octreotide bolus does not prevent intraoperative carcinoid crisis","volume":"159","author":"Condron","year":"2016","journal-title":"Surgery"},{"key":"10.1016\/j.endien.2024.03.020_bib0300","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1245\/s10434-022-11371-0","article-title":"Shifting paradigms in the pathophysiology and treatment of carcinoid crisis","volume":"29","author":"Maxwell","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.endien.2024.03.020_bib0305","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.surg.2021.03.063","article-title":"A prospective study of carcinoid crisis with no perioperative octreotide","volume":"171","author":"Wonn","year":"2022","journal-title":"Surgery"},{"key":"10.1016\/j.endien.2024.03.020_bib0310","doi-asserted-by":"crossref","first-page":"e112830","DOI":"10.5812\/aapm.112830","article-title":"Intraoperative hypotension increased risk in the oncological patient","volume":"11","author":"Mohammad Shehata","year":"2021","journal-title":"Anesth Pain Med"},{"key":"10.1016\/j.endien.2024.03.020_bib0315","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1378\/chest.115.2.598","article-title":"Coronary spasm and cardiac arrest from carcinoid crisis during laser bronchoscopy","volume":"115","author":"Mehta","year":"1999","journal-title":"Chest"},{"key":"10.1016\/j.endien.2024.03.020_bib0320","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/BF03344149","article-title":"Carcinoid crisis induced by receptor radionuclide therapy with 90Y-DOTATOC in a case of liver metastases from bronchial neuroendocrine tumor (atypical carcinoid)","volume":"29","author":"Dav\u00ec","year":"2006","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.endien.2024.03.020_bib0325","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1097\/MEG.0b013e3282294d88","article-title":"Carcinoid syndrome and carcinoid crisis secondary to a metastatic carcinoid tumour of the lung: a therapeutic challenge","volume":"19","author":"Papadogias","year":"2007","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.endien.2024.03.020_bib0330","first-page":"9810194","article-title":"Fatal systemic vasoconstriction in a case of metastatic small-intestinal NET","volume":"2017","author":"Stenzel","year":"2017","journal-title":"Case Rep Gastrointest Med"},{"key":"10.1016\/j.endien.2024.03.020_bib0335","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jcrc.2020.08.015","article-title":"Invited Commentary on \u201cOctreotide for resuscitation of cardiac arrest due to carcinoid crisis precipitated by a novel peptide receptor radionuclie therapy (PRRT): a case report\u201d","volume":"60","author":"Pommier","year":"2020","journal-title":"J Crit Care"},{"key":"10.1016\/j.endien.2024.03.020_bib0340","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.3390\/cancers14122966","article-title":"Perioperative carcinoid crisis: a systematic review and meta-analysis","volume":"14","author":"Xu","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.endien.2024.03.020_bib0345","doi-asserted-by":"crossref","first-page":"e3665","DOI":"10.1210\/clinem\/dgab289","article-title":"Peptide receptor radionuclide therapy with 177Lu-DOTATATE for symptomatic control of refractory carcinoid syndrome","volume":"106","author":"Zandee","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endien.2024.03.020_bib0350","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.3390\/jcm9072203","article-title":"Prevention and management of hormonal crisis during theragnosis with LU-DOTA-TATE in neuroendocrine tumors. A systematic review and approach proposal","volume":"9","author":"Del Olmo-Garc\u00eda","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.endien.2024.03.020_bib0355","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ctrv.2018.03.002","article-title":"Prevention and management of carcinoid crises in patients with high-risk neuroendocrine tumours undergoing peptide receptor radionuclide therapy (PRRT): literature review and case series from two Australian tertiary medical institutions","volume":"66","author":"Tapia Rico","year":"2018","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.endien.2024.03.020_bib0360","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jcrc.2020.08.011","article-title":"Octreotide for resuscitation of cardiac arrest due to carcinoid crisis precipitated by novel peptide receptor radionuclide therapy (PRRT): a case report","volume":"60","author":"Dhanani","year":"2020","journal-title":"J Crit Care"},{"key":"10.1016\/j.endien.2024.03.020_bib0365","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s00259-007-0691-z","article-title":"Hormonal crises following receptor radionuclide therapy with the radiolabeled somatostatin analogue [177Lu-DOTA0,Tyr3]octreotate","volume":"35","author":"de Keizer","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.endien.2024.03.020_bib0370","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1200\/JCO.2007.15.2553","article-title":"Treatment with the radiolabeled somatostatin analog [177 Lu-DOTA 0,Tyr3]octreotate: toxicity, efficacy, and survival","volume":"26","author":"Kwekkeboom","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.endien.2024.03.020_bib0375","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/annonc\/mdp372","article-title":"Efficacy of radionuclide treatment DOTATATE Y-90 in patients with progressive metastatic gastroenteropancreatic neuroendocrine carcinomas (GEP-NETs): a phase II study","volume":"21","author":"Cwikla","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.endien.2024.03.020_bib0380","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1038\/bjc.2013.103","article-title":"Peptide receptor radionuclide therapy with (90)Y-DOTATATE\/(90)Y-DOTATOC in patients with progressive metastatic neuroendocrine tumours: assessment of response, survival and toxicity","volume":"108","author":"Vinjamuri","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.endien.2024.03.020_bib0385","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1007\/s00259-023-06166-8","article-title":"Efficacy of [177Lu]Lu-DOTATATE in metastatic neuroendocrine neoplasms of different locations: data from the SEPTRALU study","volume":"50","author":"Mitjavila","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.endien.2024.03.020_bib0390","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1148\/radiology.174.3.2406783","article-title":"Fatal carcinoid crisis after percutaneous fine-needle biopsy of hepatic metastasis: case report and literature review","volume":"174","author":"Bissonnette","year":"1990","journal-title":"Radiology"},{"key":"10.1016\/j.endien.2024.03.020_bib0395","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/MEG.0b013e328300c4f3","article-title":"Case of carcinoid crisis following a fine-needle biopsy of hepatic metastasis","volume":"21","author":"Sinha","year":"2009","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.endien.2024.03.020_bib0400","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/0003-4975(93)90696-F","article-title":"Carcinoid crisis after biopsy of a bronchial carcinoid","volume":"56","author":"Karmy-Jones","year":"1993","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.endien.2024.03.020_bib0405","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jvir.2013.10.054","article-title":"Sudden death from carcinoid crisis during image-guided biopsy of a lung mass","volume":"25","author":"Magabe","year":"2014","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.endien.2024.03.020_bib0410","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.jvir.2021.01.264","article-title":"Percutaneous image-guided core needle biopsy of neuroendocrine tumors: how common is intraprocedural carcinoid crisis?","volume":"32","author":"Jang","year":"2021","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.endien.2024.03.020_bib0415","first-page":"143","article-title":"Carcinoid crisis 24hours after bland embolization: a case report","volume":"4","author":"Fujie","year":"2010","journal-title":"Biosci Trends"},{"key":"10.1016\/j.endien.2024.03.020_bib0420","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.euje.2006.04.008","article-title":"Carcinoid crisis and reversible right ventricular dysfunction after embolization in untreated carcinoid syndrome","volume":"8","author":"Majeed","year":"2007","journal-title":"Eur J Echocardiogr"},{"key":"10.1016\/j.endien.2024.03.020_bib0425","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1634\/theoncologist.2011-0372","article-title":"Hepatic artery embolization for neuroendocrine tumors: postprocedural management and complications","volume":"17","author":"Lewis","year":"2012","journal-title":"Oncologist"},{"key":"10.1016\/j.endien.2024.03.020_bib0430","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00261-004-0258-4","article-title":"Radiofrequency ablation of neuroendocrine liver metastases: the Middlesex experience","volume":"30","author":"Gillams","year":"2005","journal-title":"Abdom Imaging"},{"key":"10.1016\/j.endien.2024.03.020_bib0435","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s001340050060","article-title":"Carcinoid crisis during transesophageal echocardiography","volume":"26","author":"Janssen","year":"2000","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.endien.2024.03.020_bib0440","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1053\/crad.1999.0167","article-title":"Carcinoid crisis provoked by mammographic compression of metastatic carcinoid tumour of the breast","volume":"56","author":"Ozgen","year":"2001","journal-title":"Clin Radiol"},{"key":"10.1016\/j.endien.2024.03.020_bib0445","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1445-5994.2012.02719.x","article-title":"Carcinoid crisis induced by repeated abdominal examination","volume":"42","author":"Morrisroe","year":"2012","journal-title":"Intern Med J"},{"key":"10.1016\/j.endien.2024.03.020_bib0450","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.7326\/0003-4819-65-6-1334","article-title":"New understanding of the mechanism of the carcinoid flush","volume":"65","author":"Mason","year":"1966","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.endien.2024.03.020_bib0455","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1172\/JCI105475","article-title":"Abnormal forearm vascular responses in the carcinoid syndrome: the role of kinisns and kinin-generating system","volume":"45","author":"Mason","year":"1966","journal-title":"J Clin Invest"},{"key":"10.1016\/j.endien.2024.03.020_bib0460","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.amjsurg.2018.12.070","article-title":"B-Adrenergic agonist administration is not associated with secondary carcinoid crisis in patients with carcinoid tumor","volume":"217","author":"Limbach","year":"2019","journal-title":"Am J Surg"},{"key":"10.1016\/j.endien.2024.03.020_bib0465","first-page":"603","article-title":"Hemodynamic course during ablation and selective hepatic artery embolization for metastatic liver carcinoid: a retrospective observational study","volume":"73","author":"Vinzant","year":"2023","journal-title":"Braz J Anesthesiol"},{"key":"10.1016\/j.endien.2024.03.020_bib0470","doi-asserted-by":"crossref","DOI":"10.1245\/s10434-023-14876-4","article-title":"Comparison of octreotide and vasopressors as first-line treatment for intraoperative carcinoid crisis","author":"McCully","year":"2024","journal-title":"Ann Surg Oncol"}],"container-title":["Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed.)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2530018024000751?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2530018024000751?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T07:05:47Z","timestamp":1720508747000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2530018024000751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S2530018024000751"],"URL":"https:\/\/doi.org\/10.1016\/j.endien.2024.03.020","relation":{},"ISSN":["2530-0180"],"issn-type":[{"value":"2530-0180","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Carcinoid crisis: The challenge is still there","name":"articletitle","label":"Article Title"},{"value":"Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed.)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.endien.2024.03.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 SEEN and SED. Published by Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}